BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  Hyperfine Reports Third Quarter 2022 Financial Results

  Hyperfine, Inc., the creator of Swoop®, the world’s first FDA-cleared portable MRI system™, reported financial results for the quarter ended September 30, 2022 and provided a business update.

  November 10, 2022

   · 

  11 min read
• Business

  IntelGenx Reports Third Quarter 2022 Financial Results

  IntelGenx Technologies Corp. reported financial results for the third quarter ended September 30, 2022.

  November 10, 2022

   · 

  6 min read
• Business

  Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments

  Dyadic International, Inc. announced its financial results for the third quarter of 2022, and highlighted recent company developments.

  November 10, 2022

   · 

  17 min read
• Pharm Country

  Aclaris Therapeutics to Participate in Two November 2022 Healthcare Investor Conferences

  Aclaris Therapeutics, Inc. announced that the company will participate in two November healthcare investor conferences.

  November 10, 2022

   · 

  1 min read
• Business

  Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update

  Eyenovia, Inc. announced its financial and operating results for the third quarter ended September 30, 2022.

  November 10, 2022

   · 

  12 min read
• Business

  Adverum Biotechnologies Reports Third Quarter 2022 Financial Results

  Adverum Biotechnologies, Inc., a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, announced financial results for the third quarter ended September 30, 2022.

  November 10, 2022

   · 

  11 min read
• Business

  Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

  Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announced its financial results for the three and nine months ended September 30, 2022 and provided a business update.

  November 10, 2022

   · 

  15 min read